Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-18-020968

Options or other derivatives

  • Director acquired 37,954 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Klein Peter S Director 2018-03-16 Grant or award · Stock Option (right to buy) +37,954 37,954 D
Loading xslF345X03/doc4.xml…